Generics - North America, Pricing

Filter

Current filters:

North AmericaPricing

Popular Filters

Drug swap drives down costs for US Medicare

23-08-2013

Therapeutic drug substitutions have the potential to double or even triple annual cost savings compared…

FinancialGenericsHealthcareNorth AmericaPricing

Court rules in novel False Claims Act case where one pharma firm sues another viewed by HP&M lawyer

28-04-2013

The US District Court for the Central District of California issued a ruling recently in an unusual,…

AmphastarGenericsLegalLovenoxNorth AmericaPharmaceuticalPricingSanofi

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices

16-01-2013

A new study published in the Annals of Internal Medicine that provides a snapshot of a simplified cost/benefit…

Anti-viralsAtriplaGenericsGilead SciencesNorth AmericaPharmaceuticalPricingStribild

US physician acquiescence to patient demands for brand-name drugs, slammed in JAMA article

09-01-2013

Prescribing brand-name drugs when generic drugs are available generates unnecessary medical expenditures…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPricing

Express Scripts finds most used Rx drugs price hikes six times that of overall US inflation

29-11-2012

The US Prescription Price Index shows that, since September 2011, price inflation for the most highly…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalPricing

Survey reveals 98.9% of US physicians experienced cancer drug shortages in last 12 months

15-11-2012

The Community Oncology Alliance (COA), a US non-profit organization, announced the results of a drug…

GenericsHealthcareNorth AmericaOncologyPharmaceuticalPricing

Prescription drug costs: USA versus UK

04-11-2012

In the USA, the cost paid for statins (drugs to lower cholesterol) in people under the age of 65 who…

Cardio-vascularEuropeGastro-intestinalsGenericsNorth AmericaPharmaceuticalPricing

US Medicare prescription drug premiums to remain steady for third straight year

07-08-2012

Average basic premiums for Medicare prescription drug plans in the USA are projected to remain constant…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPricing

Generic Rx drugs saved US health system $1 trillion over past decade; study

03-08-2012

Due to the ever growing use of generic prescription medicines, the American health care system saved…

GenericsHealthcareMarkets & MarketingNorth AmericaPricing

Alabama Supreme Court ruling favors Sandoz in Medicaid pricing case

16-07-2012

The USA's Alabama Supreme Court came out in favor of Sandoz, the generics subsidiary of Swiss drug major…

GenericsLegalNorth AmericaNovartisPricingSandoz

No observable difference between generic and branded statins in preventing CV events; study

05-06-2012

People taking the most commonly used generic and branded statins to control their cholesterol had similar…

Cardio-vascularGenericsNorth AmericaPharmaceuticalPricing

High expectations for new US biosimilars following FDA guidance documents

10-05-2012

In light of the upcoming FDA guidance for biosimilar approval, Novation, health care supply chain expertise…

BiotechnologyGenericsNorth AmericaPricingRegulation

US medicines spending rose 3.7% in 2011, held back by healthcare reforms, IMS study reveals

05-04-2012

Total health care spending on medicines in the USA increased 3.7% to $320 billion in 2011, a year which…

BiotechnologyGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalPricing

US drug price rises nearly double inflation rate, claims AARP

08-03-2012

A look at US retail prices for a combined set of widely used prescription drugs finds the cumulative…

GenericsHealthcareNorth AmericaPharmaceuticalPricing

New US GAO report highlights critical role of generics in containing health spending

04-03-2012

Prescription drug spending in the USA reached $307 billion in 2010 - an increase of $135 billion since…

GenericsHealthcareNorth AmericaPricing

US Senators question Pfizer deals to limit access to generic Lipitor

02-12-2011

Three prominent US Senators have sent letters to pharma behemoth Pfizer (NYSE: PF), as well as three…

Cardio-vascularGenericsNorth AmericaPfizerPharmaceuticalPoliticsPricing

Brand drug 'Co-pay Coupons' undermine generics, raise health costs by $1.1 billion in US state of Michigan

17-11-2011

The proliferation of brand drug "co-pay coupon" promotions, which lure insured consumers from generics…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalPricing

Kohl-Grassley generic drug bill would save US taxpayers nearly $4.8 billion, says CBO

09-11-2011

A new estimate from the USA’s Congressional Budget Office (CBO) estimate finds that a bipartisan…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsPricing

AstraZeneca launches new Crestor savings card in USA, as generic Lipitor about to debut

07-11-2011

The US subsidiary of Anglo-Swedish drug major AstraZeneca (LSE: AZN) yesterday launched a new savings…

AstraZenecaCardio-vascularCrestorGenericsLipitorNorth AmericaPfizerPharmaceuticalPricing

US Rep Bass introduces legislation to save taxpayer money under Medicaid

07-11-2011

US Congressman Charles Bass (Republican, New Hampshire) has introduced bipartisan legislation in the…

GenericsLegalNorth AmericaPricing

Use of generic Rx drugs saved US consumers and the health care system $931 billion over past 10 years, study finds

23-09-2011

An independently conducted analysis showing that the use of generic prescription drugs in the USA has…

GenericsMarkets & MarketingNorth AmericaPricing

Impax confirms patent challenge to GlaxoSmithKline’s Jalyn; Albemarle hikes API prices

14-09-2011

US generic drugmaker Impax Laboratories (Nasdaq: IPXL) confirms that it has initiated a challenge of…

AlbemarleAvodartGenericsGlaxoSmithKlineImpax LaboratoriesJalynLegalNorth AmericaPatentsPricing

Back to top